검색어 : 통합검색[Dutoit Charles]
총 59건 중 59건 출력
, 5/6 페이지
-
41
- Combinatorial peptide library-based identification of peptide ligands for tumor-reactive cytolytic T lymphocytes of unknown specificity
- Rubio-Godoy, Verena; Ayyoub, Maha; Dutoit, Valerie; Servis, Catherine; Schink, Amy; Rimoldi, Donata; Romero, Pedro; Cerottini, Jean-Charles; Simon, Richard; Zhao, Yindong; Houghten, Richard A.; Pinilla, Clemencia; Valmori, Danila; Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (CHUV), Lausanne, Switzerland; Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (CHUV), Lausanne, Switzerland; Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (CHUV), Lausanne, Switzerland; Institute of Biochemistry, University of Lausanne, Epalinges, Switzerland; Mixture Science, Inc., San Diego, USA; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Switzerland; Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (CHUV), Lausanne, Switzerland; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Switzerland; Molecular Statistics and Bioinformatics Section, Biometric Research Branch, National Cancer Institute, NIH, Bethesda, USA; Molecular Statistics and Bioinformatics; (European journal of immunology, v.32, 2002, pp.2292-2299)
-
42
- Efficient Simultaneous Presentation of NY-ESO-1/LAGE-1 Primary and Nonprimary Open Reading Frame-Derived CTL Epitopes in Melanoma
- Rimoldi, Donata; Rubio-Godoy, Verena; Dutoit, Valerie; Lienard, Danielle; Salvi, Suzanne; Guillaume, Philippe; Speiser, Daniel; Stockert, Elisabeth; Spagnoli, Giulio; Servis, Catherine; Cerottini, Jean-Charles; Lejeune, Ferdy; Romero, Pedro; Valmori, Danila; *Ludwig Institute for Cancer Research, Lausanne Branch,; ‡Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, Lausanne Branch, and; ‡Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, Lausanne Branch, and; ‡Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, Lausanne Branch, and; *Ludwig Institute for Cancer Research, Lausanne Branch,; ¶Ludwig Institute for Cancer Research, New York Branch, New York, NY 10021; and; §Multidisciplinary Oncology Center, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; ; ¶Ludwig Institute for Cancer Research, New York Branch, New York, NY 10021; and; ∥Department of Surgery, University of Basel, Basel, Switzerland; †Institute of Biochemistry, University of Lausanne, Epalinges, Switzerland; ; *Ludwig Institute for Cancer Research, Lausanne Branch,; §Multidisciplinary Oncology Center, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerla; (The journal of immunology : official journal of the American Association of Immunologists, v.165, 2000, pp.7253-7261)
-
43
- Titanium in GGBS-like calcium-magnesium-aluminosilicate glasses: Its role in the glass network, dissolution at alkaline pH and surface layer formation
- Blotevogel, Simon; Poirier, Mathilde; Vantelon, Delphine; Chesneau, Erwan; Dutoit, Charles-E; Montouillout, Valé rie; Fayon, Franck; Kaknics, Judit; Landrot, Gautier; Saldi, Giuseppe D.; Schott, Jacques; Vezin, Hervé ; Patapy, Cedric; Cyr, Martin; ; (Journal of non-crystalline solids, v.591, 2022, pp.121708)
-
44
- Therapeutic cancer vaccines based on molecularly defined human tumor antigens
- Romero, Pedro; Pittet, Mikael; Dutoit, Valerie; Zippelius, Alfred; Lié nard, Danielle; Lejeune, Ferdy; Guillaume, Philippe; Rimoldi, Donata; Valmori, Danila; Speiser, Daniel E; Cerottini, Jean-Charles; ; (Vaccine, v.20, 2002, pp.A2-A7)
-
45
- Functional Avidity of Tumor Antigen-Specific CTL Recognition Directly Correlates with the Stability of MHC/Peptide Multimer Binding to TCR
- Dutoit, Valé rie; Rubio-Godoy, Verena; Doucey, Marie-Agnè s; Batard, Pascal; Lié nard, Danielle; Rimoldi, Donata; Speiser, Daniel; Guillaume, Philippe; Cerottini, Jean-Charles; Romero, Pedro; Valmori, Danila; *Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, and; *Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, and; ‡Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Switzerland; *Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, and; *Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, and; ‡Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Switzerland; *Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, and; ‡Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Switzerland; *Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, and; *Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, and; *Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, and; (The journal of immunology : official journal of the American Association of Immunologists, v.168, 2002, pp.1167-1171)
-
46
- SSX antigens as tumor vaccine targets in human sarcoma.
- Ayyoub, Maha; Brehm, Michelle; Metthez, Genevi?ve; Talbot, Susan; Dutoit, Valerie; Taub, Robert N; Keohan, Mary-Louise; Gure, Ali O; Chen, Yao-Tseng; Williamson, Barbara; Jungbluth, Achim A; Old, Lloyd J; Hesdorffer, Charles S; Valmori, Danila; ; (Cancer immunity a journal of the Academy of Cancer Immunology, v.3, 2003, pp.13)
-
47
- Vaccination with a Melan-A Peptide Selects an Oligoclonal T Cell Population with Increased Functional Avidity and Tumor Reactivity
- Valmori, Danila; Dutoit, Valerie; Schnuriger, Valerie; Quiquerez, Anne-Lise; Pittet, Mikaë l J.; Guillaume, Philippe; Rubio-Godoy, Verena; Walker, Paul R.; Rimoldi, Donata; Lié nard, Danielle; Cerottini, Jean-Charles; Romero, Pedro; Dietrich, Pierre-Yves; *Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, and; *Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, and; ‡Division of Oncology, Laboratory of Tumor Immunology, University Hospital, Geneva, Switzerland; and; ‡Division of Oncology, Laboratory of Tumor Immunology, University Hospital, Geneva, Switzerland; and; *Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, and; §Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Switzerland; *Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, and; ‡Division of Oncology, Laboratory of Tumor Immunology, University Hospital, Geneva, Switzerland; and; §Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Switzerland; *Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, and; *Division of Clinical Onco-Immunology, Ludwig Institute; (The journal of immunology : official journal of the American Association of Immunologists, v.168, 2002, pp.4231-4240)
-
48
- Leveraging synteny to generate reference genomes for conservation: Assembling the genomes of Hector’s and Māui dolphins
- Costes Sebastian Alvarez; Baker Charles; Constantine Rochelle; Carroll Emma; Guhlin Joseph; Dutoit Ludovic; Ferreira Sara; Heimeier Dorothea; Gemmell Neil; Gillum Joanne; Hamner Rebecca; Rayment Will; Roe Wendi; Aika Ben Te; Urban Lara; Alexander Alana; University of Otago; Oregon State University; University of Auckland; The University of Auckland; ; University of Otago Department of Zoology; University of Otago; The University of Auckland - City Campus; University of Otago; University of Otago; Oregon State University; ; Massey University School of Veterinary Science; University of Otago; University of Otago; University of Otago; (, v., 2024, )
-
49
- Degeneracy of Antigen Recognition as the Molecular Basis for the High Frequency of Naive A2/Melan-A Peptide Multimer <sup>+</sup> CD8 <sup>+</sup> T Cells in Humans
- Dutoit, Valé rie; Rubio-Godoy, Verena; Pittet, Mikä el J.; Zippelius, Alfred; Dietrich, Pierre-Yves; Legal, Fré dé rique Anne; Guillaume, Philippe; Romero, Pedro; Cerottini, Jean-Charles; Houghten, Richard A.; Pinilla, Clemencia; Valmori, Danila; Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (CHUV), 1011 Lausanne, Switzerland; Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (CHUV), 1011 Lausanne, Switzerland; Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (CHUV), 1011 Lausanne, Switzerland; Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (CHUV), 1011 Lausanne, Switzerland; Division of Oncology, Laboratory of Tumor Immunology, University Hospital (HUG), Geneva 1211, Switzerland; Division of Oncology, Laboratory of Tumor Immunology, University Hospital (HUG), Geneva 1211, Switzerland; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges 1066, Switzerland; Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (CHUV), 1011 Lausanne, Switzerland; Ludwig Ins; (The Journal of experimental medicine, v.196, 2002, pp.207-216)
-
50
- Circulating Tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(-) effector subset exerting ex vivo tumor-specific cytolytic activity.
- Valmori, Danila; Scheibenbogen, Carmen; Dutoit, Valerie; Nagorsen, Dirk; Asemissen, Anne Marie; Rubio-Godoy, Verena; Rimoldi, Donata; Guillaume, Philippe; Romero, Pedro; Schadendorf, Dirk; Lipp, Martin; Dietrich, Pierre-Yves; Thiel, Eckhard; Cerottini, Jean-Charles; Lié nard, Danielle; Keilholz, Ulrich; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.62, 2002, pp.1743-1750)
QUICK MENU
